YAP1 and cancer: Although mutations and altered expressions of a group of Hippo pathway genes that lead to the increased activity of coactivators YAP and TAZ and an overgrowth phenotype have been observed in human cancer [56,60,61], the core Hippo pathway genes are infrequently mutated.